U.S. Markets closed

Quanterix Corporation (QTRX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
58.30+0.78 (+1.36%)
At close: 4:00PM EDT

57.76 -0.54 (-0.93%)
After hours: 4:07PM EDT

Quanterix Corporation

Building 1
900 Middlesex Turnpike
Billerica, MA 01821
United States
617 301 9400
http://www.quanterix.com

Sector(s)Healthcare
IndustryMedical Devices
Full Time Employees314

Key Executives

NameTitlePayExercisedYear Born
Mr. E. Kevin HrusovskyChairman, Pres & CEO1.31MN/A1962
Dr. David R. WaltCo-Founder, Chairman of Scientific Advisory Board & Independent Director41kN/A1953
Mr. Amol ChaubalChief Financial Officer501.87kN/A1976
Mr. John J. FryGen. Counsel & Corp. Sec.465kN/A1961
Mr. Bruce J. BalVP of Operations, Service & QualityN/AN/A1959
Mr. William GeistChief Operating OfficerN/AN/AN/A
Dr. David C. Duffy Ph.D.Sr. VP of R&D and CTON/AN/A1971
David PanzerellaVP of SalesN/AN/AN/A
Dr. Mark T. RoskeySr. VP of Commercial & AcceleratorN/AN/A1960
Dr. Dawn R. Mattoon Ph.D.Sr. VP of Research ProductsN/AN/A1973
Amounts are as of December 31, 2019 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Quanterix Corporation, a life sciences company, develops and markets digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a sensitive automated multiplex protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection technology in various applications, including direct detection of nucleic acids. It also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include assay kits and other consumables such as reagents. In addition, it offers contract research services, including sample testing, homebrew assay development, and custom development services. The company primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation. It sells its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct sales force, support organizations, and distributors or sales agents. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.

Corporate Governance

Quanterix Corporation’s ISS Governance QualityScore as of April 1, 2021 is 10. The pillar scores are Audit: 8; Board: 10; Shareholder Rights: 8; Compensation: 10.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.